Intestinal Colonization by Vancomycin-Resistant Enterococci in Cancer Patients with Risk Factors

被引：0

作者：

Talavera, Griselda ^{[1
]}

Rodriguez, Magdalena ^{[2
]}

Castro, Hector ^{[2
]}

Melgarejo, Nancy ^{[3
]}

Noguera, Jabibi ^{[1
]}

Portillo, Susan ^{[1
]}

Basualdo, Wilma ^{[2
,4
]}

机构：

[1] Hosp Gen Pediat Ninos Acosta NU, Serv Oncohematol, San Lorenzo, Paraguay

[2] Hosp Gen Pediat Ninos Acosta NU, Dpto Epidemiol & Enfermedades Infecciosas, Programa Prevenc & Control Infecc Intrahosp, San Lorenzo, Paraguay

[3] Hosp Gen Pediat Ninos Acosta NU, Bacteriol Lab, San Lorenzo, Paraguay

[4] Hosp Gen Pediat Ninos Acosta NU, Bacigalupo C-Avda Victoria Reducto, San Lorenzo, Paraguay

来源：

PEDIATRIA-ASUNCION | 2011年 / 38卷 / 02期

关键词：

Vancomycin-resistant enterococci; intestinal colonization; cancer patients; pediatrics;

D O I：

暂无

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

The study objectives were to determine the prevalence of intestinal colonization by vancomycin-resistant enterococci (VRE) in cancer patients with risk factors and describe their clinical and demographic characteristics. A longitudinal study conducted between December 1, 2008 and March 30, 2010, in patients aged <= 18 years. A total of 33 patients were included. VRE were isolated in 94% (31/33), of whom 39% (12/31) were age 10-14 years. 58% (18/31) were male, and 21/31 presented acute lymphoblastic leukemia (ALL). All had previously received antibiotics, 90% (28/31) vancomycin. 84% (26/31) had central venous catheters (CVC), 2/31 had surgery, and 1/31 MV. Contact precautions were implemented. In conclusion, a high rate of VRE colonization was observed. CVC and use of vancomycin were predominant. It is important to continue the established measures, monitoring, and the prudent use of vancomycin.

引用

页码：123 / 125

页数：3

共 9 条

[1]

[Anonymous], 1995, INFECT CONT HOSP EP, V16, P105

[2]

Braun S, 2009, REV CHIL INFECTOL, V26, P374, DOI /S0716-10182009000500014

[3]

Giamberardino HI, 2008, 9 C INT FED INF CONT

[4] SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of staphylococcus aureus and enterococcus [J].

Muto, CA ;

Jernigan, JA ;

Ostrowsky, BE ;

Richet, HM ;

Jarvis, WR ;

Boyce, JM ;

Farr, BM .

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2003, 24 (05) :362-386

[5]

Paredes W, 2010, REV MED HERED, V21, P128

[6]

Reale AL, 2009, REV ARGENT MICROBIOL, V41, P92

[7]

Riera E, 2009, HSDCDA63208 SAIDI OP

[8]

Samudio G, 2009, 6 WORLD C WORLD SOC

[9] Epidemiology and mechanisms of glycopeptide resistance in enterococci [J].

Zirakzadeh, A ;

Patel, R .

CURRENT OPINION IN INFECTIOUS DISEASES, 2005, 18 (06) :507-512

← 1 →